Agan FJ - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

The Dual Androgen Receptor and Glucocorticoid Receptor Antagonist CB-03-10 as Potential Treatment for Tumors that have Acquired GR-mediated Resistance to AR Blockade.

Rosette C, Agan FJ, Rosette N, Mazzetti A, Moro L, Gerloni M. Rosette C, et al. Among authors: agan fj. Mol Cancer Ther. 2020 Nov;19(11):2256-2266. doi: 10.1158/1535-7163.MCT-19-1137. Epub 2020 Aug 26. Mol Cancer Ther. 2020. PMID: 32847976

Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition.

Rosette C, Agan FJ, Rosette N, Moro L, Mazzetti A, Hassan C, Gerloni M. Rosette C, et al. Among authors: agan fj. Drug Metab Pharmacokinet. 2019 Jun;34(3):172-180. doi: 10.1016/j.dmpk.2019.01.002. Epub 2019 Jan 17. Drug Metab Pharmacokinet. 2019. PMID: 31101589 Free article.

Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro.

Rosette C, Agan FJ, Mazzetti A, Moro L, Gerloni M. Rosette C, et al. Among authors: agan fj. J Drugs Dermatol. 2019 May 1;18(5):412-418. J Drugs Dermatol. 2019. PMID: 31141847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters